Led by Elena Rozhkova, scientists from the US Department of Energy’s (DOE) Argonne National Laboratory and the University of Chicago’s Brain Tumour Centre have developed the first nanoparticles that seek out and destroy glioblastoma multiforme (GBM) brain cancer cells without damaging nearby healthy cells
Share this Story